AHOD2131: A Randomized Phase 3 Response-Adapted Trial Comparing Standard Therapy to Immuno-oncology for Children & Adults with Newly Diagnosed Stage I and II Hodgkin Lymphoma

J Seelisch, B Hu, L A Renfro, F G Keller, A DuVall, T O Henderson, Y Wu, SY-H Cho, B S Hoppe, S Milgrom, L G Roth, N S Grover, A S LaCasce, J M Kahn, S Yao, S K Parson, N Khan, R M Vega, P S Hinds, P B Allen, A M Evens, H Schoder, S M Castellino, K M Kelly · Klinische Pädiatrie · 2025 · Heft 06 · S. 359-360